Save (your) face stop smoking

By ACSH Staff — Dec 21, 2011
A new study has found more evidence to link cigarette smoking to one type of skin cancer, supporting earlier studies that have observed significant associations between the two. This study, published in Cancer Causes Control, found a significantly increased risk of squamous cell carcinoma among female smokers.

A new study has found more evidence to link cigarette smoking to one type of skin cancer, supporting earlier studies that have observed significant associations between the two. This study, published in Cancer Causes Control, found a significantly increased risk of squamous cell carcinoma among female smokers.

Hit the bottle, ladies!

By ACSH Staff — Dec 21, 2011
Women who get their tan from a bottle are less likely to expose themselves to harmful UV rays, according to a study just published in the Archives of Dermatology.

Women who get their tan from a bottle are less likely to expose themselves to harmful UV rays, according to a study just published in the Archives of Dermatology.

The bird is the word. But should we censor it?

By ACSH Staff — Dec 21, 2011
Two separate research groups have reportedly developed strains of bird flu (avian influenza type A [H5N1]) that may be transmissible between humans. However, just as the studies were set to appear in the journals Nature and Science, the U.S. National Science Advisory Board for Biosecurity (NSABB) asked that the journals omit key research data from the publication.

Two separate research groups have reportedly developed strains of bird flu (avian influenza type A [H5N1]) that may be transmissible between humans. However, just as the studies were set to appear in the journals Nature and Science, the U.S. National Science Advisory Board for Biosecurity (NSABB) asked that the journals omit key research data from the publication.

Gasping for accuracy asthma headlines smother the facts

By ACSH Staff — Dec 20, 2011
"Asthma drugs in pregnancy may raise risk for kids," a recent USA Today headline warns. ACSH's Dr. Gilbert Ross, however, is more concerned about the newspaper s misleading message. If you continue to read the article, he points out, you realize that the reporter is referring specifically to inhaled anti-inflammatory steroid asthma medications not asthma drugs in general, as the headline implies.

"Asthma drugs in pregnancy may raise risk for kids," a recent USA Today headline warns. ACSH's Dr. Gilbert Ross, however, is more concerned about the newspaper s misleading message. If you continue to read the article, he points out, you realize that the reporter is referring specifically to inhaled anti-inflammatory steroid asthma medications not asthma drugs in general, as the headline implies.

Fewer clean needles, more communicable disease

By ACSH Staff — Dec 20, 2011
Protecting IV drug users from dangerous diseases by allowing them access to clean needles is a cost effective and sound public health policy that we should not abandon, writes ACSH friend Dr. Art Caplan, director of the Center for Bioethics at the University of Pennsylvania, in a piece for MSNBC. Nevertheless, Congressional Republicans have proposed to curtail or abandon funding for clean needle exchange programs. Dr.

Protecting IV drug users from dangerous diseases by allowing them access to clean needles is a cost effective and sound public health policy that we should not abandon, writes ACSH friend Dr. Art Caplan, director of the Center for Bioethics at the University of Pennsylvania, in a piece for MSNBC. Nevertheless, Congressional Republicans have proposed to curtail or abandon funding for clean needle exchange programs. Dr.

Impeding harm reduction is harmful

By ACSH Staff — Dec 20, 2011
In a two-part series for his blog, Tobacco Analysis, ACSH advisor Dr. Michael Siegel, a professor in the Department of Community Health Sciences at the Boston University School of Public Health, details the most serious barrier yet to tobacco harm reduction. Dr.

In a two-part series for his blog, Tobacco Analysis, ACSH advisor Dr. Michael Siegel, a professor in the Department of Community Health Sciences at the Boston University School of Public Health, details the most serious barrier yet to tobacco harm reduction. Dr.

Running on empty

By ACSH Staff — Dec 19, 2011
Knowing that they ll have to jog for 50 minutes to burn off one soda may keep teenagers from buying such beverages. A recent study published in the American Journal of Public Health found that, when a sign stating the amount of jogging time required to burn off one soda was placed on a drink cooler, inner-city teenagers in four neighborhood stores were only half as likely to buy a sugary beverage.

Knowing that they ll have to jog for 50 minutes to burn off one soda may keep teenagers from buying such beverages. A recent study published in the American Journal of Public Health found that, when a sign stating the amount of jogging time required to burn off one soda was placed on a drink cooler, inner-city teenagers in four neighborhood stores were only half as likely to buy a sugary beverage.

More hope for MS patients

By ACSH Staff — Dec 19, 2011
A late-stage trial of the drug Gilenya (fingolimod) has brought good news for patients with relapsing-remitting multiple sclerosis (RRMS), a disease for which treatments have become more effective and common over the past decade.

A late-stage trial of the drug Gilenya (fingolimod) has brought good news for patients with relapsing-remitting multiple sclerosis (RRMS), a disease for which treatments have become more effective and common over the past decade.

Prevention of cervical cancer gets even better

By ACSH Staff — Dec 19, 2011
Adding HPV (human papillomavirus) screening to conventional Pap tests appears to significantly improve the early detection of precancerous cervical abnormalities and reduce the rate of subsequent cervical cancer, according to a new study in The Lancet Oncology.

Adding HPV (human papillomavirus) screening to conventional Pap tests appears to significantly improve the early detection of precancerous cervical abnormalities and reduce the rate of subsequent cervical cancer, according to a new study in The Lancet Oncology.